IR-MED Granted Patent in Israel for its AI-Driven Platform Technology: Non-Invasive Analysis of Subcutaneous Tissue
December 07, 2023 09:15 ET
|
IR-Med, Inc.
The Granted patent covers IR-MED’s PressureSafe™ decision support device for the early detection of pressure injuries addressing a healthcare burden that amounts to $26.8 billion in the U.S. annually...
Malachite Innovations Retains Investment Banking Firm to Assist in Implementation of Strategic Plan for Cannabinoid Drug Development Business
December 07, 2023 09:15 ET
|
Malachite Innovations, Inc.
Company will focus on core impact investing strategy in Appalachia CLEVELAND, OHIO, Dec. 07, 2023 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”) announces that it...
LI-CYCLE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Li-Cycle To Contact Him Directly To Discuss Their Options
December 07, 2023 09:15 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $50,000 investing in Li-Cycle securities between June 14, 2022 and October 23, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
OUTLOOK INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Outlook To Contact Him Directly To Discuss Their Options
December 07, 2023 09:15 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $50,000 investing in Outlook securities between December 29, 2022 and August 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
FMC INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In FMC To Contact Him Directly To Discuss Their Options
December 07, 2023 09:15 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in FMC securities between November 2, 2022 and October 30, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
KENVUE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Kenvue To Contact Him Directly To Discuss Their Options
December 07, 2023 09:15 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement")...
Hodges Capital Selects Ultimus as Fund Administrator for Series of Mutual Funds
December 07, 2023 09:15 ET
|
Ultimus Fund Solutions
Ultimus chosen as new service provider based on flexibility and consultative approach for administration of Hodges Capital's multiple mutual funds.
DOCGO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In DocGo To Contact Him Directly To Discuss Their Options
December 07, 2023 09:15 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in DocGo securities between November 8, 2022 and September 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
LIVEPERSON INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In LivePerson To Contact Him Directly To Discuss Their Options
December 07, 2023 09:15 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $50,000 investing in LivePerson stock or options between May 10, 2022 and March 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Medical Robotic Systems Market Size Worth USD 94.33 Billion in 2032 | Emergen Research
December 07, 2023 09:14 ET
|
Emergen Research
Vancouver, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global medical robotic systems market size was USD 21.20 Billion in 2022 and is expected to register a revenue CAGR of 16.1% during the forecast...